Ronen Arbel

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 30

Top Venues

Nature medicine

Diabetes, obesity & metabolism

The New England journal of medicine

Heart (British Cardiac Society)

Sapir College

Ben-Gurion University of the Negev Faculty of Health Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sapir College Feb 10 2015

Israel

chairperson :: Technology Marketing

Ben-Gurion University of the Negev Faculty of Health Sciences Oct 01 2012

Israel

Lecturer and Researcher :: Health Systems Management

Education History

Ben-Gurion University of the Negev Faculty of Health Sciences Oct 01 2012 - Jun 15 2014

Israel

PHD :: Health Systems Management

Publications

Yael Wolff Sagy, Gil Lavie, Noga Ramot, Erez Battat, Ronen Arbel, Orna Reges, Dror Dicker
Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure. Nature medicine 30 (8) (2024)
Yael Wolff Sagy, Gil Lavie, Noga Ramot, Erez Battat, Ronen Arbel, Orna Reges, Dror Dicker
Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure. Nature medicine (2024)
Yael Wolff Sagy, Gil Lavie, Noga Ramot, Erez Battat, Ronen Arbel, Orna Reges, Dror Dicker
Effectiveness of Bariatric Metabolic Surgery versus Glucagon-Like Peptide-1 Receptor Agonists for prevention of Congestive Heart Failure. Nature medicine (2024)
Yael Wolff Sagy, Gil Lavie, Noga Ramot, Erez Battat, Ronen Arbel, Orna Reges, Dror Dicker
Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure. Nature medicine (2024)
Yael Wolff Sagy, Gil Lavie, Noga Ramot, Erez Battat, Ronen Arbel, Orna Reges, Dror Dicker
Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure. Nature medicine (2024)
Yael Wolff Sagy, Gil Lavie, Noga Ramot, Erez Battat, Ronen Arbel, Orna Reges, Dror Dicker
Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure. Nature medicine 30 (8) (2024)
Yael Wolff Sagy, Gil Lavie, Noga Ramot, Erez Battat, Ronen Arbel, Orna Reges, Dror Dicker
Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure. Nature medicine (2024)
Yael Wolff Sagy, Roy Zucker, Ariel Hammerman, Hila Markovits, Noa Gur Arieh, Wiessam Abu Ahmad, Erez Battat, Noga Ramot, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Ronen Arbel, Gil Lavie, Doron Netzer
Real-world effectiveness of a single dose of mpox vaccine in males. Nature medicine 29 (3) (2023)
Yael Wolff Sagy, Roy Zucker, Ariel Hammerman, Hila Markovits, Noa Gur Arieh, Wiessam Abu Ahmad, Erez Battat, Noga Ramot, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Ronen Arbel, Gil Lavie, Doron Netzer
Real-world effectiveness of a single dose of mpox vaccine in males. Nature medicine (2023)
Yael Wolff Sagy, Roy Zucker, Ariel Hammerman, Hila Markovits, Noa Gur Arieh, Wiessam Abu Ahmad, Erez Battat, Noga Ramot, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Ronen Arbel, Gil Lavie, Doron Netzer
Real-world effectiveness of a single dose of mpox vaccine in males. Nature medicine (2023)
Yael Wolff Sagy, Roy Zucker, Ariel Hammerman, Hila Markovits, Noa Gur Arieh, Wiessam Abu Ahmad, Erez Battat, Noga Ramot, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Ronen Arbel, Gil Lavie, Doron Netzer
Real-world effectiveness of a single dose of mpox vaccine in males. Nature medicine 29 (3) (2023)
Yael Wolff Sagy, Roy Zucker, Ariel Hammerman, Hila Markovits, Noa Gur Arieh, Wiessam Abu Ahmad, Erez Battat, Noga Ramot, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Ronen Arbel, Gil Lavie, Doron Netzer
Real-world effectiveness of a single dose of mpox vaccine in males. Nature medicine (2023)
Ramesh Nadarajah, Jianhua Wu, David Hogg, Keerthenan Raveendra, Yoko M Nakao, Kazuhiro Nakao, Ronen Arbel, Moti Haim, Doron Zahger, John Parry, Christopher Bates, Campbel Cowan, Chris P Gale
Prediction of short-term atrial fibrillation risk using primary care electronic health records. Heart (British Cardiac Society) (2023)
Ramesh Nadarajah, Jianhua Wu, Ronen Arbel, Moti Haim, Doron Zahger, Talish Razi Benita, Lior Rokach, J Campbell Cowan, Chris P Gale
Risk of atrial fibrillation and association with other diseases: protocol of the derivation and international external validation of a prediction model using nationwide population-based electronic health records. BMJ open 13 (12) (2023)
Yael Wolff Sagy, Roy Zucker, Ariel Hammerman, Hila Markovits, Noa Gur Arieh, Wiessam Abu Ahmad, Erez Battat, Noga Ramot, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Ronen Arbel, Gil Lavie, Doron Netzer
Real-world effectiveness of a single dose of mpox vaccine in males. Nature medicine 29 (3) (2023)
Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, Ben Sluckis, Ronen Arbel
Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis. Diabetes, obesity & metabolism 25 (4) (2022)
Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, Ben Sluckis, Ronen Arbel
Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis. Diabetes, obesity & metabolism (2022)
Ronen Arbel, Yael Wolff Sagy, Moshe Hoshen, Erez Battat, Gil Lavie, Ruslan Sergienko, Michael Friger, Jacob G Waxman, Noa Dagan, Ran Balicer, Yatir Ben-Shlomo, Alon Peretz, Shlomit Yaron, Danielle Serby, Ariel Hammerman, Doron Netzer
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge. The New England journal of medicine 387 (9) (2022)
Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, Ben Sluckis, Ronen Arbel
Tirzepatide vs. Semaglutide for Weight Loss In Patients With Type 2 Diabetes Mellitus - A Value For Money Analysis. Diabetes, obesity & metabolism (2022)
Ariel Hammerman, Candace Makeda Moore, Enis Aboalhasan, Joseph Azuri, Ronen Arbel
Oral versus subcutaneous semaglutide for prevention of major adverse cardiovascular events: cost per outcome analysis of SUSTAIN-6 and PIONEER-6. Postgraduate medicine 134 (7) (2022)
Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, Ben Sluckis, Ronen Arbel
Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis. Diabetes, obesity & metabolism 25 (4) (2022)
Ronen Arbel, Joseph Pliskin
Vaccinations versus Lockdowns to Prevent COVID-19 Mortality. Vaccines 10 (8) (2022)
Ariel Hammerman, Ruslan Sergienko, Michael Friger, Tanya Beckenstein, Alon Peretz, Doron Netzer, Shlomit Yaron, Ronen Arbel
Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19. The New England journal of medicine 386 (13) (2022)
Joseph Azuri, Ariel Hammerman, Enis Aboalhasan, Ben Sluckis, Ronen Arbel
Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis. Diabetes, obesity & metabolism 25 (4) (2022)
Ronen Arbel, Ruslan Sergienko, Michael Friger, Alon Peretz, Tanya Beckenstein, Shlomit Yaron, Doron Netzer, Ariel Hammerman
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years. Nature medicine 28 (7) (2022)
Ronen Arbel, Ariel Hammerman, Ruslan Sergienko, Michael Friger, Alon Peretz, Doron Netzer, Shlomit Yaron
BNT162b2 Vaccine Booster and Mortality Due to Covid-19. The New England journal of medicine (2021)
Ariel Hammerman, Joseph Azuri, Enis Aboalhasan, Ronen Arbel
Dapagliflozin Versus Sacubitril-Valsartan to Improve Outcomes of Patients with Reduced Ejection Fraction and Diabetes Mellitus. American journal of cardiovascular drugs : drugs, devices, and other interventions (2021)
Ronen Arbel, Enis Aboalhasan, Ariel Hammerman, Joseph Azuri
Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis. Clinical drug investigation 40 (7) (2020)
Ronen Arbel, Ruslan Sergienko, Ariel Hammerman, Sari Dotan-Greenberg, Erez Batat, Orly Avnery, Dan Greenberg, Martin H Ellis
Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation. Heart (British Cardiac Society) 105 (19) (2019)
Ronen Arbel, Dan Greenberg
Using lower cost statins improves outcomes for normal cholesterol non-diabetic patients. Expert review of pharmacoeconomics & outcomes research 17 (5) (2017)

Ronen Arbel.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ronen Arbel